Back to GUGGENHEIM CAPITAL LLC GUGGENHEIM CAPITAL LLC

GILDGILD
Showing 8 of 30 quarters

Position history for GUGGENHEIM CAPITAL LLCGUGGENHEIM CAPITAL LLC's holdings in GILEAD SCIENCES INC

Yes. Guggenheim Capital holds 416,657 shares of GILD (Gilead Sciences), worth $52.6M, as of its Q2 2026 13F filing. It increased the position by 203 shares (+0.1%) from Q1 2026. Guggenheim Capital has held GILD in every 13F on record since Q1 2019, 30 quarterly filings. GILD is 0.3% of Guggenheim Capital's reported 13F portfolio.

Current Value

$52.6M

Current Shares

416,657

Total Value Change

-$4.5M

Total Shares Change

-264,833

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
416,657
+0.1%
$52.6M0.3%$125.63
35
2026-Q1
Decreased
416,454
-19.6%
$58M0.5%$137.68
0
2025-Q4
Decreased
517,789
-2.1%
$63.6M0.5%$120.57
0
2025-Q3
Decreased
528,863
-5.7%
$58.7M0.4%$108.32
0
2025-Q2
Increased
560,937
+5.6%
$62.2M0.5%$107.45
37
2025-Q1
Decreased
531,224
-17.9%
$59.5M0.5%$107.83
0
2024-Q4
Decreased
647,253
-5.0%
$59.8M0.5%$88.27
0
2024-Q3
Decreased
681,490
-12.4%
$57.1M0.4%$79.45
0

Other major holders of GILD: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used